NetMHCIIphosPan: A Machine Learning Tool for Predicting HLA Class II Antigen Presentation of Phosphorylated Peptides
- 17 April 2026
- journal article
- Published by American Chemical Society (ACS) in Journal of Proteome Research
- Vol. 25 (5) , 2529-2545
Abstract
Phosphorylated peptides presented by human leukocyte antigen (HLA) class II molecules play pivotal roles in immune regulation, yet their characterization and prediction remain challenging due to data noise and limited HLA coverage. Here, we introduce NetMHCIIphosPan, a prediction method for HLA-II antigen presentation of phosphorylated peptides, developed using mass spectrometry (MS)-based immunopeptidomics data sets. Employing a refined peptide identification workflow, we reanalyzed earlier HLA-II phospholigand data sets and trained predictive models, achieving superior performance compared to models trained on the original data. Binding motif analysis revealed that HLA-specific preferences for phospholigands closely aligned with those of unmodified ligands. Incorporating unmodified ligands into training further enhanced predictive accuracy, particularly for HLA-DP and HLA-DQ molecules. NetMHCIIphosPan outperformed existing tools, such as NetMHCIIpan-4.3 and MixMHC2pred-1.3, for prediction of HLA antigen presentation of phosphorylated peptides, demonstrating robustness and utility. This work establishes NetMHCIIphosPan as a state-of-the-art tool for understanding the HLA-II phospholigandome, with potential applications in immunotherapy and vaccine design.Keywords
Funding Information
- National Cancer Institute (U24CA248138)
- National Institute of Allergy and Infectious Diseases (75N93019C00001)
- Cancer Research UK (C328/A21998)
This publication has 48 references indexed in Scilit:
- Computational approaches to identify sites of phosphorylationProteomics, 2023
- Machine learning predictions of MHC-II specificities reveal alternative binding mode of class II epitopesImmunity, 2023
- Mapping the SARS-CoV-2 spike glycoprotein-derived peptidome presented by HLA class II on dendritic cellsCell Reports, 2021
- Defining HLA-II Ligand Processing and Binding Rules with Mass Spectrometry Enhances Cancer Epitope PredictionImmunity, 2019
- HLA-DRB1 the notorious gene in the mosaic of autoimmunityImmunologic Research, 2016
- Global, In Vivo, and Site-Specific Phosphorylation Dynamics in Signaling NetworksCell, 2006
- T cell recognition and therapeutic effect of a phosphorylated synthetic peptide of the 70K snRNP protein administered in MRL/lpr miceEuropean Journal of Immunology, 2003
- Characterization of phosphoproteins from electrophoretic gels by nanoscale Fe(III) affinity chromatography with off-line mass spectrometry analysisProteomics, 2001
- The effects of post-translational side-chain modifications on the stimulatory activity, serum stability and conformation of synthetic peptides carrying T helper cell epitopesBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1996
- Isolation of phosphoproteins by immobilized metal (Fe3+) affinity chromatographyAnalytical Biochemistry, 1986